Table 1
Comparison of NMSs and QoL between ET Patients and Controls
| ET patients | Controls | p* | |
|---|---|---|---|
| N = 30 | N = 30 | ||
| Age | 45.20 ± 18.10 (18–76) | 43.43 ± 17.27 (19–77) | 0.700 |
| FTMRS_TOTAL | 42.10 ± 13.80 (19–79) | ||
| (1) Tremor severity | 17.10 ± 6.20 (7–33) | ||
| (2) Handwriting | 15.73 ±5 .30 (8–28) | ||
| (3) Functional disability | 9.40 ± 3.59 (4–18) | ||
| MoCA | 25.73 ± 3.04 (21–30) | 27.40 ± 2.34 (24–30) | 0.021 |
| BDI | 13.33±6.00 (70%) | 8.77 ± 4.16 (26.7%) | 0.001 |
| HARS | 15.67 ± 6.25 | 9.70 ± 4.47 | <0.001 |
| PSQI | 6.13 ± 2.87 | 4.40 ± 2.53 | 0.016 |
| Non-motor symptoms scale* | |||
| NMSS Total | 58.03 ± 21.50 (100%) | 17.20 ± 11.80 (96.7%) | <0.001 |
| (1) Cardiovascular | 4.17 ± 3.60 (80%) | 1.00 ± 1.51 (43.3%) | <0.001 |
| (2) Sleep/fatigue | 10.53 ± 6.07 (100%) | 4.10 ± 3.52 (80%) | <0.001 |
| (3) Mood/cognition | 17.57 ± 7.67 (100%) | 5.43 ± 3.77 (83.3%) | <0.001 |
| (4) Perceptual problems | 1.37 ± 1.87 (46.6%) | 0.23 ± 0.63 (13.3%) | 0.003 |
| (5) Attention/memory | 8.13 ± 5.19 (100%) | 2.83 ± 3.09 (73.3%) | <0.001 |
| (6) Gastrointestinal symptoms | 1.50 ± 2.70 (43.3%) | 0.17 ± 0.46 (13.3%) | 0.010 |
| (7) Urinary symptoms | 1.10 ± 1.90 (30%) | 0.33 ± 0.71 (20%) | 0.043 |
| (8) Sexual function | 4.13 ± 3.51 (70%) | 0.53 ± 1.25 (16.7 %) | <0.001 |
| (9) Miscellaneous | 9.53 ± 4.88 (96.6%) | 2.57 ± 3.01(56.7%) | <0.001 |
| HRQoL Subscales** | |||
| (1) Physical Functioning (PF) | 57.17 ±11.24 | 79.15±11.43 | <0.001 |
| (2) Role physical (RP) | 58.12±10.23 | 77.43±9.72 | <0.001 |
| (3) Bodily pain (BP) | 58.42±11.43 | 76.25±7.200 | <0.001 |
| (4) General health (GH) | 61.72±10.881 | 77.92±11.077 | <0.001 |
| (5) Vitality (VT) | 54.23±11.80 | 74.93±9.44 | <0.001 |
| (6) Role-emotional (RE) | 52.25±11.62 | 77.63±8.32 | <0.001 |
| (7) Mental health (MH) | 51.47±11.13 | 76.58±11.864 | <0.001 |
| (8) Social functioning (SF) | 52.71±9.31 | 75.40±9.062 | <0.001 |
Abbreviations: BDI, Beck Depression Inventory; HARS, Hamilton Anxiety Rating Scale; MoCA, Montreal Cognitive Assessment; NMSS, Non-Motor Symptoms Scale; PSQI, Pittsburgh Sleep Quality Index; SD, Standard Deviation. p < 0.05: significant; p < 0.001: highly significant; * Compared by student’s t-tests.
Table 2
Correlations of HRQoL with NMSs in ET Patients
| PF | RP | RE | VT | MH | SF | BP | GH | ||
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | r | −0.674 | −0.623 | −0.642 | −0.697 | −0.610 | −0.536 | −0.560 | −0.627 |
| p | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | 0.002* | 0.001* | <0.001* | |
| Sleep/fatigue | r | −0.601 | −0.597 | −0.680 | −0.553 | −0.701 | −0.619 | −0.515 | −0.513 |
| p | <0.001* | <0.001* | <0.001* | 0.002* | <0.001* | <0.001* | 0.004* | 0.004* | |
| Mood/cognition | r | −0.640 | −0.693 | −0.692 | −0.547 | −0.631 | −0.588 | −0.561 | −0.587 |
| p | <0.001* | <0.001* | <0.001* | 0.002* | <0.001* | 0.001* | 0.001* | 0.001* | |
| Perceptual abnormalities | r | −0.064 | 0.076 | 0.017 | −0.021 | 0.157 | 0.205 | 0.027 | −0.113 |
| p | 0.738 | 0.689 | 0.929 | 0.911 | 0.408 | 0.276 | 0.889 | 0.553 | |
| Attention/memory | r | −0.467 | −0.408 | −0.683 | −0.688 | −0.677 | −0.622 | −0.474 | −0.585 |
| p | 0.009* | 0.025* | <0.001* | <0.001* | <0.001* | <0.001* | 0.008* | 0.001* | |
| Gastrointestinal | r | −0.182 | −0.177 | −0.354 | −0.293 | −0.178 | −0.311 | −0.259 | −0.344 |
| p | 0.335 | 0.349 | 0.055 | 0.117 | 0.346 | 0.094 | 0.167 | 0.063 | |
| Urinary | r | −0.185 | −0.176 | −0.082 | −0.163 | 0.009 | −0.015 | −0.162 | −0.074 |
| p | 0.328 | 0.351 | 0.668 | 0.391 | 0.962 | 0.935 | 0.394 | 0.699 | |
| Sexual function | r | −0.420 | −0.334 | −0.335 | −0.539 | −0.249 | −0.392 | −0.393 | −0.275 |
| p | 0.021* | 0.071 | 0.070 | 0.002* | 0.185 | 0.032* | 0.032* | 0.141 | |
| Miscellaneous | r | −0.533 | −0.578 | −0.437 | −0.569 | −0.359 | −0.439 | −0.607 | −0.478 |
| p | 0.002* | 0.001* | 0.016* | 0.001* | 0.052* | 0.015* | <0.001* | 0.008* | |
| NMS total | r | −0.858 | −0.836 | −0.916 | −0.904 | −0.819 | −0.811 | −0.800 | −0.813 |
| p | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* |
[i] Abbreviations: BP, Bodily Pain; GH, General Health; MH, Mental Health; NMS, Non-Motor Symptoms; PF, Physical Functioning; RE, Role Emotional; RP, Role-Physical; SF, Social Functioning; VT, Vitality. p < 0.05: significant. p < 0.001: highly significant. Correlations by Pearson Correlation Coefficient; Italics values indicates significant of p values.
Table 3
Comparison of Neuropsychiatric Symptoms and NMS between ET Patients and Controls
| Younger ET patients ≤ 45 years | Older ET patients 45 years | p* | Younger controls ≤ 45 years | p* | Older controls > 45 years | p* | |
|---|---|---|---|---|---|---|---|
| Number | 14 | 16 | 17 | 13 | |||
| Age | 28.14 ± 8.22 | 60.13 ± 8.09 | <0.001 | 29.71 ± 4.77 | 0.513 | 61.39 ± 8.62 | 0.689 |
| MoCA | 27.43 ± 2.59 | 24.25 ± 2.65 | 0.003 | 29.12 ± 1.11 | 0.021 | 25.15 ±1.41 | 0.277 |
| BDI | 12.43 ± 6.63 | 14.13 ± 5.49 | 0.450 | 8.23 ± 4.92 | 0.056 | 9.39 ± 2.96 | 0.009 |
| PSQI | 5.50 ± 2.10 | 6.69 ± 3.38 | 0.266 | 4.24 ± 2.93 | 0.187 | 4.62 ± 1.98 | 0.062 |
| NMSS total | 50.43 ± 14.18 | 64.69 ± 24.86 | 0.069 | 10.53 ± 7.38 | <0.001 | 25.92 ± 10.87 | <0.001 |
| (1) Cardiovascular | 3.79 ± 3.87 | 4.50 ± 3.43 | 0.596 | 0.06 ± 0.24 | <0.001 | 2.23 ± 1.59 | 0.037 |
| (2) Sleep/fatigue | 8.07 ± 5.50 | 12.69 ± 5.87 | 0.035 | 3.53 ± 3.48 | 0.009 | 4.85 ± 3.56 | <0.001 |
| (3) Mood/cognition | 16.43 ± 6.51 | 18.56 ± 8.64 | 0.457 | 4.65 ± 3.2 | <0.001 | 6.46 ± 4.20 | <0.001 |
| (4)Perceptual problems | 1.71 ± 2.46 | 1.06 ± 1.123 | 0.349 | 0 | 0.007 | 0.54 ± 0.88 | 0.181 |
| (5)Attention/memory | 6.29 ± 4.08 | 9.75 ± 5.63 | 0.067 | 1.18 ± 1.29 | <0.001 | 5.00 ± 3.44 | 0.013 |
| (6) Gastrointestinal symptoms | 1.64 ± 2.47 | 1.38 ± 2.96 | 0.792 | 0 | 0.01 | 0.39 ± 0.65 | 0.249 |
| (7) Urinary symptoms | 0.64 ± 1.74 | 1.50 ± 2.00 | 0.224 | 0 | 0.136 | 0.77 ± 0.93 | 0.236 |
| (8) Sexual function | 2.86 ± 3.39 | 5.25 ± 3.32 | 0.006 | 0 | 0.002 | 1.23 ± 1.69 | <0.001 |
| (9) Miscellaneous | 9.00 ± 5.41 | 10.00 ± 4.50 | 0.585 | 1.12 ± 2.23 | <0.001 | 4.46 ± 2.90 | 0.001 |
Abbreviations: BDI, Beck Depression Inventory; MoCA, Montreal Cognitive Assessment; NMSS, Non-Motor Symptoms Scale; PSQI, Pittsburgh Sleep Quality Index; SD, Standard Deviation. p < 0.05: significant. p < 0.001: highly significant.
